http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50#head http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50 http://www.nanopub.org/nschema#hasAssertion http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50#assertion http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50 http://www.nanopub.org/nschema#hasProvenance http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50#provenance http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50 http://www.nanopub.org/nschema#hasPublicationInfo http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50#assertion http://rdf.disgenet.org/resource/gda/DGNa0824ba53651e76965976abd61712595 http://semanticscience.org/resource/SIO_000628 http://identifiers.org/ncbigene/4547 http://rdf.disgenet.org/resource/gda/DGNa0824ba53651e76965976abd61712595 http://semanticscience.org/resource/SIO_000628 http://linkedlifedata.com/resource/umls/id/C0023474 http://rdf.disgenet.org/resource/gda/DGNa0824ba53651e76965976abd61712595 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://semanticscience.org/resource/SIO_001123 http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50#provenance http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50#assertion http://purl.org/dc/terms/description [Imatinib mesylate (Gleevec, STI-571) is an inhibitor of ABL tyrosine kinase activity that has been remarkably effective in slowing disease progression in patients with chronic phase chronic myelogenous leukemia, but the emergence of imatinib resistance underscores the need for additional therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine. http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50#assertion http://purl.org/ontology/wi/core#evidence http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50#assertion http://semanticscience.org/resource/SIO_000772 http://identifiers.org/pubmed/15781610 http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://rdf.disgenet.org/v5.0.0/void/BEFREE http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50#assertion http://www.w3.org/ns/prov#wasGeneratedBy http://purl.obolibrary.org/obo/ECO_0000203 http://rdf.disgenet.org/v5.0.0/void/BEFREE http://purl.org/pav/importedOn 2017-02-19 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://purl.obolibrary.org/obo/ECO_0000212 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#comment Gene-disease associations inferred from text-mining the literature. http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#label DisGeNET evidence - LITERATURE http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50 http://purl.org/dc/terms/created 2017-10-17T13:14:49+02:00 http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50 http://purl.org/dc/terms/rights http://opendatacommons.org/licenses/odbl/1.0/ http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50 http://purl.org/dc/terms/rightsHolder http://rdf.disgenet.org/v5.0.0/void/IBIGroup http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50 http://purl.org/dc/terms/subject http://semanticscience.org/resource/SIO_000983 http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50 http://purl.org/net/provenance/ns#usedData http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50 http://purl.org/pav/authoredBy http://orcid.org/0000-0001-5999-6269 http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50 http://purl.org/pav/authoredBy http://orcid.org/0000-0002-7534-7661 http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50 http://purl.org/pav/authoredBy http://orcid.org/0000-0002-9383-528X http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50 http://purl.org/pav/authoredBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50 http://purl.org/pav/authoredBy http://orcid.org/0000-0003-1244-7654 http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50 http://purl.org/pav/createdBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP726006.RAsIHUS5XC15P5yavOMGxf-OSMdID4wtKYnAE_olM5Z50 http://purl.org/pav/version v5.0.0.0 http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://purl.org/pav/version v5.0.0